Please provide your email address to receive an email when new articles are posted on . The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat ...
BITS Pilani's new nanomedicine gel shows promising preclinical results for rheumatoid arthritis treatment, enhancing drug delivery and reducing inflammation.
In today’s fast-paced world, joint pain and discomfort have become increasingly common, affecting millions of individuals across all age groups. The search for effective and natural solutions for ...
Cortrophin Gel is the only FDA-approved purified corticotropin (ACTH) indicated for the treatment of appropriate patients with acute gouty arthritis flares New 1-mL size furthers ANI’s commitment to ...
BAUDETTE, Minn.--(BUSINESS WIRE)-- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...
A groundbreaking study from the Journal of the American Chemical Society introduces a new “smart” drug delivery material that could transform how people manage chronic conditions like arthritis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results